Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

109.39
+0.24000.22%
Post-market: 109.390.00000.00%16:05 EDT
Volume:81.14K
Turnover:8.91M
Market Cap:2.11B
PE:-496.22
High:111.42
Open:110.85
Low:108.50
Close:109.15
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 27, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K/A [Amend] - Current report
Dec 03, 2020

Major Issues Report

8-K - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]